Posts

Showing posts with the label cancer

IB Net Payout Yields Model

Moderna: Focus On Cancer Vaccines, Not Buyout

Image
Update - Aug. 19, 2026 MODERNA, MERCK  MRNA  CANCER VACCINE SUCCEEDS IN PHASE 3, stock up nearly 150% to $153 mid-day trading. The stock is now up nearly 500% from where our research highlighted the potential benefits of a cancer vaccine.  - MRNA  and  MRK  say their personalized mRNA cancer vaccine, intismeran, combined with Keytruda slowed melanoma recurrence and spread in a late-stage trial. -The study was stopped at its first interim analysis after positive results, though detailed efficacy data have not yet been released.   Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our subscriber-only portfolios.  Learn More » Original article posted on Oct. 31, 2025 Moderna surged on reports of talks with a large biopharma for a potential partnership or buyout, despite trading at multi-year lows. MRNA's promising cancer vaccine data and surprising findings on mRNA Covid vaccines boosting cancer surv...